Exactly this. There's absolutely nothing about what Dr T posts on HC that's not already publicly available to everyone and the market. If they were, HC wouldn't have allowed him to post and ASX would've raised alarm bells by now.
HC is just like another social media platform like Twitter, Facebook, LinkedIn, emails or even Race Oncology's website. What Dr.T has done is gone the extra mile and take time to answer many questions that many existing or potential SHs have. Given the complexity nature of oncology drugs, trials, approvals and history of Bisantrene, it's invaluable to have a company representative to provide information and clarify misinformation/false rumours, which we can all agree it's very common on RAC threads.
I believe more ASX companies should follow what Race has done and hire someone who's knowledgeable and the patience to answer both genuine questions and trolls who are obviously trying to downramp RAC by asking "why can't we cure cancer already".
I just wanted to thank Dr.T for his massive effort for answering questions day in and day out and I believe it definitely gives SHs a massive boost of confidence knowing that Race is constantly engaged with the public. Transparency is key and I've seen way too often where ASX companies just gone quiet and things went south not long after.
GLTAH and DYOR
RAC Price at posting:
$3.90 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)